Wang Shan-Wei1, Xu Kan-Lun2, Ruan Shu-Qin3, Zhao Li-Li3, Chen Li-Rong2. 1. Key Laboratory of Cancer Prevention and Intervention (China National Ministry of Education), The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Hangzhou, China ; Department of Pathological Anatomy, School of Basic Medicine, Xi'an Medical College, Xi'an, Hangzhou, China. 2. Department of Pathology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China. 3. Key Laboratory of Cancer Prevention and Intervention (China National Ministry of Education), The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Hangzhou, China.
Abstract
BACKGROUND: The aim of this study was to investigate the expression of caveolin-1 (Cav-1) in cancer-associated fibroblasts (CAFs) and to explore its correlation with clinicopathologic parameters and prognosis. MATERIALS AND METHODS: Cav-1 expression was detected in the stroma of 143 patients with breast cancer, 10 patients with ductal carcinoma in situ (DCIS), and 10 normal breast tissue samples. RESULTS: Overexpression of stromal Cav-1 in breast cancer was associated with histological type, low histological grade, estrogen receptor (ER) negativity, and molecular subtypes. The expression rate of stromal Cav-1 in breast cancer (65.7%, 94/143) was significantly higher than that of DCIS (0%, 0/10) and normal breast tissue (0%, 0/10) (p = 0.000). A positive correlation was found between stromal Cav-1 and ER (p = 0.046, rs = 0.218). Stromal Cav-1 expression in luminal B was significantly higher than in basal-like type (p = 0.048). Furthermore, stromal expression of Cav-1 was significantly correlated with the 5-year survival rate (p = 0.029), and it was an independent prognostic factor (p = 0.009). CONCLUSION: Cav-1 expression in CAFs was correlated with histological type, histological grade, ER status, and molecular subtypes in breast cancer. Stromal Cav-1 expression was an independent prognostic factor, and the absence or reduction of Cav-1 expression in stromal CAFs of invasive breast cancer predicts poor prognostic outcome.
BACKGROUND: The aim of this study was to investigate the expression of caveolin-1 (Cav-1) in cancer-associated fibroblasts (CAFs) and to explore its correlation with clinicopathologic parameters and prognosis. MATERIALS AND METHODS:Cav-1 expression was detected in the stroma of 143 patients with breast cancer, 10 patients with ductal carcinoma in situ (DCIS), and 10 normal breast tissue samples. RESULTS: Overexpression of stromal Cav-1 in breast cancer was associated with histological type, low histological grade, estrogen receptor (ER) negativity, and molecular subtypes. The expression rate of stromal Cav-1 in breast cancer (65.7%, 94/143) was significantly higher than that of DCIS (0%, 0/10) and normal breast tissue (0%, 0/10) (p = 0.000). A positive correlation was found between stromal Cav-1 and ER (p = 0.046, rs = 0.218). Stromal Cav-1 expression in luminal B was significantly higher than in basal-like type (p = 0.048). Furthermore, stromal expression of Cav-1 was significantly correlated with the 5-year survival rate (p = 0.029), and it was an independent prognostic factor (p = 0.009). CONCLUSION:Cav-1 expression in CAFs was correlated with histological type, histological grade, ER status, and molecular subtypes in breast cancer. Stromal Cav-1 expression was an independent prognostic factor, and the absence or reduction of Cav-1 expression in stromal CAFs of invasive breast cancer predicts poor prognostic outcome.
Entities:
Keywords:
Biomarker; Breast cancer; Cancer-associated fibroblasts; Gene; Prognosis
Authors: Agnieszka K Witkiewicz; Abhijit Dasgupta; Katherine H Nguyen; Chengbao Liu; Albert J Kovatich; Gordon F Schwartz; Richard G Pestell; Federica Sotgia; Hallgeir Rui; Michael P Lisanti Journal: Cancer Biol Ther Date: 2009-06-29 Impact factor: 4.742
Authors: Agnieszka K Witkiewicz; Abhijit Dasgupta; Federica Sotgia; Isabelle Mercier; Richard G Pestell; Michael Sabel; Celina G Kleer; Jonathan R Brody; Michael P Lisanti Journal: Am J Pathol Date: 2009-05-01 Impact factor: 4.307
Authors: Erica K Sloan; Daniel R Ciocca; Normand Pouliot; Anthony Natoli; Christina Restall; Michael A Henderson; Mariel A Fanelli; Fernando D Cuello-Carrión; Francisco E Gago; Robin L Anderson Journal: Am J Pathol Date: 2009-05-01 Impact factor: 4.307
Authors: Heather M Brechbuhl; Alexander S Barrett; Etana Kopin; Jaime C Hagen; Amy L Han; Austin E Gillen; Jessica Finlay-Schultz; Diana M Cittelly; Philip Owens; Kathryn B Horwitz; Carol A Sartorius; Kirk Hansen; Peter Kabos Journal: JCI Insight Date: 2020-02-27